Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices 13135 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the Medical Liability 

and Safety Innovation Projects (R21) 

applications are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: Medical Liability and 

Safety Innovation Projects (R2l) 

Date: April 2, 2010 (Open on April 2 from 

8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting) 

Place: Doubletree Bethesda Hotel & 

Executive Meeting Center, 8120 Wisconsin 

Avenue, Conference Room TBD, Bethesda, 

Maryland 20852. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

This notice is published less than 15 days 

in advance of the meeting date due to 

logistical difficulties. 

Dated: March 8, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–5744 Filed 3–17–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the Medical Liability 

and Safety Demonstration Projects (R18) 

applications are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: Medical Liability and 

Safety Demonstration Projects (R18). 

Date: March 31–April 1, 2010 (Open on 

March 31 from 8 a.m. to 8:15 a.m. and closed 

for the remainder of the meeting). 

Place: Doubletree Bethesda Hotel & 

Executive Meeting Center, 8120 Wisconsin 

Avenue, Conference Room TBD, Bethesda, 

Maryland 20852. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

This notice is published less than 15 days 

in advance of the meeting date due to 

logistical difficulties. 

Dated: March 8, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–5698 Filed 3–17–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the OS ARRA: 

Expansion of Research Capabilities to 

Study CE Complex Patients (R24) 

applications are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: OS ARRA: Expansion of 

Research Capabilities to Study CE Complex 

Patients (R24). 

Date: April 5–6, 2010 (Open on April 5 

from 8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting). 

Place: Bethesda North Marriott, 5701 

Marinelli Road, Conference Room TBD, 

Bethesda, Maryland 20852. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 


sroberts on DSKD5P82C1PROD with NOTICES
13136 Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices 

Agenda items for this meeting are subject 

to change as priorities dictate. 

This notice is published less than 15 days 

in advance of the meeting date due to 

logistical difficulties. 

Dated: March 8, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–5682 Filed 3–17–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biomedical Library 

and Informatics Review Committee. 

Date: June 10–11, 2010. 

Time: June 10, 2010, 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Time: June 11, 2010, 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Arthur A. Petrosian, PhD, 

Chief Scientific Review Officer, Division of 

Extramural Programs, National Library of 

Medicine, 6705 Rockledge Drive, Suite 301, 

Bethesda, MD 20892–7968, 301–496–4253, 

petrosia@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: March 9, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–5680 Filed 3–17–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Loan 

Repayment. 

Date: March 22, 2010. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Virtual Meeting) 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH. 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 9, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–5678 Filed 3–17–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the Board of 

Regents of the National Library of 

Medicine. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Regents of 

the National Library of Medicine; 

Subcommittee on Outreach and Public 

Information. 

Date: May 11, 2010. 

Time: 7:30 a.m. to 8:45 a.m. 

Agenda: Outreach Activities. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Conference Room B, 

8600 Rockville Pike, Bethesda, MD 20892. 

Contact Person: Donald A.B. Lindberg, MD, 

Director, National Library Of Medicine, 8600 

Rockville Pike, Bethesda, MD 20894, 301– 

496–6221, lindberg@mail.nih.gov. 

Name of Committee: Board of Regents of 

the National Library of Medicine. 

Date: May 11–12, 2010. 

Open: May 11, 2010, 9 a.m. to 4:30 p.m. 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Closed: May 11, 2010, 4:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Open: May 12, 2010, 9 a.m. to 12 p.m. 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Donald A.B. Lindberg, MD, 

Director, National Library of Medicine, 8600 

Rockville Pike, Bethesda, MD 20894, 301– 

496–6221, lindberg@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 


sroberts on DSKD5P82C1PROD with NOTICES